Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/13/2012EP2462147A1 Conformationally constrained, fully synthetic macrocyclic compounds
06/13/2012EP2462145A1 Prasugrel in non-crystalline form and pharmaceutical composition thereof
06/13/2012EP2462144A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
06/13/2012EP2462143A1 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators
06/13/2012EP2462142A1 Metabotropic glutamate receptor modulators
06/13/2012EP2462141A1 Novel azaheterocyclic compounds
06/13/2012EP2462139A1 Sphingosine-1-phosphate receptor agonists
06/13/2012EP2462138A1 Antiviral compounds and methods of making and using there of cross reference to related applications
06/13/2012EP2462136A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors
06/13/2012EP2462135A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors
06/13/2012EP2462131A2 Compositions and methods for treating beta-amyloid related diseases
06/13/2012EP2462128A2 Compounds as lysophosphatidic acid receptor antagonists
06/13/2012EP2462123A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
06/13/2012EP2462122A1 Novel viral replication inhibitors
06/13/2012EP2462121A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors
06/13/2012EP2462117A1 Quinolinyloxyphenylsulfonamides
06/13/2012EP2462116A2 Process for the manufacture of pharmaceutically active compounds
06/13/2012EP2462110A2 Dp2 antagonist and uses thereof
06/13/2012EP2462105A1 Amino-alcohol analogues and uses thereof
06/13/2012EP2461869A1 Novel bicyclic urea compounds
06/13/2012EP2461835A1 Compositions containing jarid1b inhibitors and methods for treating cancer
06/13/2012EP2461820A1 Orally administerable pharmaceutical preparation containing insulin
06/13/2012EP2461815A1 Method of preventing renal disease and treating symptoms thereof
06/13/2012EP2461814A2 Treatment of prostate cancer
06/13/2012EP2461813A1 Compositions and methods for inducing apoptosis in prostate cancer cells
06/13/2012EP2461812A1 Composition for the treatment of cystic fibrosis
06/13/2012EP2461811A1 Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv
06/13/2012EP2461810A1 Methods of using c-met modulators
06/13/2012EP2461809A2 Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
06/13/2012EP2461808A2 Methods for enhancing the cognitive function
06/13/2012EP2461807A1 Co-therapy for the treatment of epilepsy and related disorders
06/13/2012EP2461806A2 Antiangiogenic small molecules and methods of use
06/13/2012EP2461805A1 Spectinamides as anti-tuberculosis agents
06/13/2012EP2461804A2 Greater utility with thyroid hormone
06/13/2012EP2461803A2 Fast-acting naproxen composition with reduced gastrointestinal effects
06/13/2012EP2461802A1 Controlled-release granular compositions containing mesalazine and process for the manufacture thereof
06/13/2012EP2461801A2 Controlled release pharmaceutical compositions of milnacipran
06/13/2012EP2461797A1 Process for preparation of over-the-counter gelatin or pectin-based drug delivery
06/13/2012EP2461796A2 Sublingual and buccal film compositions
06/13/2012EP2461795A2 Sublingual and buccal film compositions
06/13/2012EP2461701A1 Food formulation comprising glycogen
06/13/2012EP2461691A1 Therapeutic vitamin d sun-protecting formulations and methods for their use
06/13/2012EP2461690A1 Lipidated oxoadenine derivatives
06/13/2012EP2461682A1 Methods of treating autism spectrum disorders and compositions for same
06/13/2012EP2461679A1 Vaccine stabilizer
06/13/2012EP2307435B1 Salts of hiv inhibitor compounds
06/13/2012EP2271321B1 Pharmaceutical composition 271
06/13/2012EP2215068B1 Antidiabetic tricyclic compounds
06/13/2012EP2200596B1 Method of treating gaucher disease
06/13/2012EP2079485B1 Phenylpropionamide compounds and the use thereof
06/13/2012EP2023920B1 Cannabinoid receptor antagonists/inverse agonists
06/13/2012EP2010185B1 Dihydrothienopyrimidine for treating inflammatory disorders
06/13/2012EP2001841B1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
06/13/2012EP1989205B1 Thiophene-carboxamides useful as inhibitors of protein kinases
06/13/2012EP1986650B1 Tamper resistant dosage forms
06/13/2012EP1979311B1 Phenoxy acetic acids as ppar delta activators
06/13/2012EP1944291B1 Optically active cyclic alcohol compound and method for producing same
06/13/2012EP1937253B1 Combined preparation of o-acetylsalicylic acid salts
06/13/2012EP1912973B1 Crystalline forms of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide
06/13/2012EP1877061B1 Method and composition for inhibiting cell proliferation and angiogenesis
06/13/2012EP1842558B1 Composition for inhibiting expression of target gene
06/13/2012EP1836180B1 Sulfonyl pyrrolidines, method for producing the same and their use as drugs
06/13/2012EP1809629B1 N,N'-diphenyl urea derivatives suitable for the treatment of tumours, eye diseases, inflammation and diseases of the immune system
06/13/2012EP1798234B1 Pharmaceutical composition comprising temozolomide ester
06/13/2012EP1797038B1 Thermodynamically stable form of bay 43-9006 tosylate
06/13/2012EP1789053B1 Method of wound healing using a2b adenosine receptor antagonists
06/13/2012EP1781635B1 Potassium channel inhibitors
06/13/2012EP1776119B9 Tetrahydro-naphthalene derivatives as glucocorticoid receptor modulators
06/13/2012EP1740192B1 Cyclic dinucleotide for stimulating the immune of inflammatory response
06/13/2012EP1740189B1 Lung surfactant supplements
06/13/2012EP1734944B1 4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
06/13/2012EP1734927B1 Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
06/13/2012EP1704145B1 Selective kinase inhibitors
06/13/2012EP1699460B1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/13/2012EP1678202B1 Hcv ns3-ns4a protease resistance mutants
06/13/2012EP1675573B2 Controlled release sterile injectable aripiprazole formulation and method
06/13/2012EP1663183B9 Solid pharmaceutical dosage form comprising ritonavir
06/13/2012EP1636585B2 Diaryl ureas with kinase inhibiting activity
06/13/2012EP1626051B1 Crystals of quinolinecarboxylic acid derivative solvate
06/13/2012EP1618087B1 Antibacterial agents
06/13/2012EP1575982B1 Promoter for the production of hyaluronic acid containing ginsenoside compound k
06/13/2012EP1569892B1 Calcilytic compounds
06/13/2012EP1552835B1 Transdermal patch for external use comprising fentanyl
06/13/2012EP1495053B1 Angiopoietin-2 and angiopoietin-1 specific binding agents
06/13/2012EP1478438B1 Methods and compositions for the treatment of asthma
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1363705B1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/13/2012EP1357912B9 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1104296B1 Bioimplant formulation
06/13/2012EP0904288B1 Vaccine comprising the pathogenic escherichia coli associated protein espa
06/13/2012EP0821690B1 Nucleotide analogues for the treatment of viral infections
06/13/2012CN1997642B 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/13/2012CN1980910B Benzopyran compound for treating arrhythmia
06/13/2012CN1926121B Thiazole derivatives and use thereof
06/13/2012CN1898212B Analogs of benzoquinone-containing ansamycins for the treatment of cancer
06/13/2012CN1849112B Therapeutic liposomes
06/13/2012CN1743337B Taxol derivative and its pharmaceutical composition
06/13/2012CN1688337B Use of digoxin immune FAB (ovine) for the regulation of sodium/potassium atpase activity in preeclamptic and eclamptic patients
06/13/2012CN1615890B Use of vitamin d compounds
1 ... 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 ... 7860